Trial intelligence / Profile preview

Real-time exhaled propofol monitoring during target-controlled infusion in general anesthesia

ChiCTR2400083945Phase 4Not yet recruiting

Sponsor
West China Hospital of Sichuan University
Start
May 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of propofol (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Concentration of exhaled propofol. Planned start May 2024; status: not yet recruiting.

02

Drugs

propofol

Beyond the preview

Go deeper on ChiCTR2400083945.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400083945.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call